367 related articles for article (PubMed ID: 33802531)
1. Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.
Jurczyk M; Jelonek K; Musiał-Kulik M; Beberok A; Wrześniok D; Kasperczyk J
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802531
[TBL] [Abstract][Full Text] [Related]
2. Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics.
Vikas ; Sahu HK; Mehata AK; Viswanadh MK; Priya V; Muthu MS
Nanomedicine (Lond); 2022 Aug; 17(19):1375-1395. PubMed ID: 36317852
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Transferrin/folate dual-targeting Pluronic F127/poly(lactic acid) polymersomes for effective anticancer drug delivery.
Wang QX; Chen X; Li ZL; Gong YC; Xiong XY
J Biomater Sci Polym Ed; 2022 Jun; 33(9):1140-1156. PubMed ID: 35179085
[TBL] [Abstract][Full Text] [Related]
5. Mediating the Fate of Cancer Cell Uptake: Dual-Targeted Magnetic Nanovectors with Biotin and Folate Surface Ligands.
Ilyas S; Ullah NK; Ilyas M; Wennhold K; Iqbal M; Schlößer HA; Hussain MS; Mathur S
ACS Biomater Sci Eng; 2020 Nov; 6(11):6138-6147. PubMed ID: 33449668
[TBL] [Abstract][Full Text] [Related]
6. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
[TBL] [Abstract][Full Text] [Related]
8. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
9. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
[TBL] [Abstract][Full Text] [Related]
10. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
[TBL] [Abstract][Full Text] [Related]
11. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
12. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Targeted Chitosan-Biotin-Conjugated Mesoporous Silica Nanoparticles as Carriers of Zinc Complexes to Achieve Enhanced Chemotherapy
Kundu BK; Pragti ; Carlton Ranjith WA; Shankar U; Kannan RR; Mobin SM; Bandyopadhyay A; Mukhopadhyay S
ACS Appl Bio Mater; 2022 Jan; 5(1):190-204. PubMed ID: 35014809
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
15. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
17. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
18. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
19. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]